期刊文献+

染色体8p上FGL1基因可能与肝癌转移相关 被引量:1

PGL1,a Candidate Metastatic Suppressor Gene of Human Hepatocellular Carcinoma
下载PDF
导出
摘要 目的:比较不同转移潜能的肝癌组织的基因表达谱差异,结合以往研究发现的有关肝癌转移相关分子遗传学异常, 以发现与肝癌转移相关基因。方法:应用基因芯片技术,比较不同转移潜能的肝癌组织标本的基因表达谱,并应用RT- PCR方法对差异表达较明显的基因进行了验证。姑果:不伴转移与伴有转移的肝癌组织之间,有989个基因存在差异表达,其中10个位于染色体8p上。选取定位于8p21.3-p22的类纤维蛋白原1基因(FGL1)(fibrinogen-like 1,同义于 HFREP1,LFIRE1),用RT-PCR的方法进行验证,结果证明FGL1在伴有转移的肝癌组织中表达明显下调。结论:不同转移潜能的肝癌组织中基因表达谱存在明显差别。染色体8p上可能存在抑制肝癌转移的基因。FGL1基因可能是一候选肝癌转移抑制基因,值得进一步研究。 To screen and identify the genes relating to the metastasis of human hepatocellular carcinoma (HCC). Methods:The difference of gene expression profiles between the HCC tissue with and without metastasis were analyzed by oligo nucleotide microarray. Based on the findings of this gene expression profiling and the previous molecular cytogenetic studies, the leading differently expressed genes were identified and selected for further analysis by semi-quantitative RT-PCR Results: 989 differently expressed genes were detected between the HCC tissues with and without metastasis. One of the leading candidate genes on chromosome 8p, FGL1, was identified. And RT-PCR analysis demonstrated that FGL1 gene was significantly down-regulated in the HCC tissues with metastasis, which further confirmed the results of the gene chips technique. Conclusion:The gene expression profiles were significantly different between the HCC tissues with and without metastasis. FGL1 on chromosome 8p might possess metastasis suppressor activity in HCC.
出处 《中国临床医学》 北大核心 2006年第1期64-66,共3页 Chinese Journal of Clinical Medicine
基金 国家杰出青年基金(30325041)国家863计划重点项目(2002BA711A02-4)教育部跨世纪优秀人才培养计划(教技函2002-48)教育部重大项目(教技司2001-171)。
关键词 肝细胞癌 转移 基因芯片 染色体8P FGL1 Hepatocellular carcinoma Metastasis Gene chips Chromosome 8p Fibrinogen--like 1
  • 相关文献

参考文献14

  • 1Parkin DM,Bray FI,Devesa SS.Cancer burden in the year 2000.The global picture[J].Eur J Cancer,2001,37 Suppl 8:4-66.
  • 2Tang ZY,YeSL,LiuYK,et al.Adecade's studes on metastasis of hepatocellular carcinoma[J].J Cancer Res Clin Oncol,2004,130:187-196.
  • 3Kanematsu T,Furui J,Yanaga K,et al.A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma:1985-2000[J].Surgery,2002,131:S153-158.
  • 4Mitsunobu M,Toyosaka A,Oriyama T,et al.Intrahepatic metastases in hepatocellular carcinoma:the role of the portal vein as an efferent vessel[J].Clin Exp Metastasis,1996,14:520-529.
  • 5Tsai TJ,Chau GY,Lui WY,et al.Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma[J].Surgery,2000,127:603-608.
  • 6Emi M,Fujiwara Y,Ohata H,et al.Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma[J].Genes Chromosomes Cancer,1993,7:152-157.
  • 7Qin LX,Tang ZY,Sham JS,et al.The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma[J].Cancer Res,1999,59:5662-5665.
  • 8Zhang LH,Qin LX,Ma ZC,et al.Allelic imbalance regions on chromosomes 8p,17p and 19p related to metastasis of hepatocellular carcinoma:comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis[J].J Cancer ResClin Oncol,2003,129:279-286.
  • 9Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumours[J].Nature,2000,406:747-752.
  • 10Weigelt B,Glas AM,Wessels LF,et al.Gene expression profiles of primary breast tumors maintained in distant metastases[J].Proc Natl Acad Sci U S A,2003,100:15901-15905.

同被引文献13

  • 1赵艳凤,姜达.癌性恶病质发生的分子机制及其逆转[J].实用肿瘤学杂志,2007,21(2):169-172. 被引量:13
  • 2雷科锋,刘炳亚,陈雪华,蔡劬,柯山,刘文韬,朱正纲.SerpinB5能促进胃癌细胞株的恶性倾向[J].上海交通大学学报(医学版),2007,27(5):508-511. 被引量:1
  • 3Stewart GD,Skipworth RJ,Fearon KC.Cancer cachexia and fatigue.Clin Med,2006,6(2):140-143.
  • 4Langhans W.Peripheral mechanisms involved with catabolism.Curr Opin Clin Nutr Metab Care,2002,5(4):419- 426.
  • 5Dodson S,Baracos VE,Jatoi A,et al.Muscle wasting in cancer cachexia:clinical implications,diagnosis,and emerging treatment strategies.Annu Rev Med,2011,62:265-279.
  • 6Tazi E,Errihani H.Treatment of cachexia in oncology.Indian J Palliat Care,2010,16(3):129-137.
  • 7Rawlings ND,Tolle DP,Barrett AJ.Evolutionary families of peptidase inhibitors.Biochem J,2004,378(Pt 3):705-716.
  • 8Bailey CM,Khalkhali-Ellis Z,Seftor EA,et al.Biological functions of maspin.J Cell Physiol,2006,209(3):617-624.
  • 9Odero-Marah VA,Khalkhali-Ellis Z,Chunthapong J,et al.Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.Cancer Biol Ther,2003,2(4):398-403.
  • 10张轶,刘文韬,李强,陈雪华,刘炳亚,朱正纲.肿瘤转移相关基因原肌球蛋白2的克隆及功能初步研究[J].中华肿瘤杂志,2007,29(9):644-648. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部